Trade Summary

2 days ago, Sr One Capital Management, LLC, serving as 10% owner at Odyssey Therapeutics, Inc. (ODTX), purchased 555,555 shares at $18.00 per share, for a total transaction value of $9,999,990.00. Following this transaction, Sr One Capital Management, LLC now holds 3,794,883 shares of ODTX.

This purchase represents a 17.00% increase in Sr One Capital Management, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 11, 2026, meaning the disclosure happened on the same day as the trade.

Odyssey Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.